These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas. Caretto A; Lanzi R; Piani C; Molgora M; Mortini P; Losa M Pituitary; 2017 Oct; 20(5):553-560. PubMed ID: 28676954 [TBL] [Abstract][Full Text] [Related]
27. Gonadotropin-producing pituitary adenoma in a man with long-standing primary hypogonadism. Nicolis G; Shimshi M; Allen C; Halmi NS; Kourides IA J Clin Endocrinol Metab; 1988 Jan; 66(1):237-41. PubMed ID: 2447114 [TBL] [Abstract][Full Text] [Related]
28. Long-term treatment with the dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or alpha-subunit secreting pituitary adenoma. Kwekkeboom DJ; Lamberts SW Clin Endocrinol (Oxf); 1992 Feb; 36(2):171-6. PubMed ID: 1348979 [TBL] [Abstract][Full Text] [Related]
29. Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. In situ hybridization and immunohistochemical analysis. Sanno N; Teramoto A; Sugiyama M; Matsuno A; Takumi I; Tahara S; Osamura RY Horm Res; 1998; 50(1):11-7. PubMed ID: 9691207 [TBL] [Abstract][Full Text] [Related]
30. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332 [TBL] [Abstract][Full Text] [Related]
31. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture. Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310 [TBL] [Abstract][Full Text] [Related]
33. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. Alexander JM; Swearingen B; Tindall GT; Klibanski A J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603 [TBL] [Abstract][Full Text] [Related]
34. Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation. Pentz-Vidovíc I; Skorić T; Grubisić G; Korsíc M; Ivicevic-Bakulic T; Besenski N; Paladino J; Plavsic V; Zarković K Eur J Endocrinol; 2000 Nov; 143(5):607-14. PubMed ID: 11078984 [TBL] [Abstract][Full Text] [Related]
35. Plasma inhibin A in heifers: relationship with follicle dynamics, gonadotropins, and steroids during the estrous cycle and after treatment with bovine follicular fluid. Bleach EC; Glencross RG; Feist SA; Groome NP; Knight PG Biol Reprod; 2001 Mar; 64(3):743-52. PubMed ID: 11207187 [TBL] [Abstract][Full Text] [Related]
36. The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. Ho DM; Hsu CY; Ting LT; Chiang H Hum Pathol; 1997 Aug; 28(8):905-11. PubMed ID: 9269826 [TBL] [Abstract][Full Text] [Related]